Disclosure Policy

The American Society for Nutrition supports fair and unbiased participation of individuals in its education activities. Any real or potential conflicts of interest must be identified and managed. All relevant financial relationships with commercial interests that directly impact and/or might conflict with ASN activities must be disclosed, or disclosure that no relevant financial relationships exist must be documented. Other relationships that could cause private interests to conflict with professional interests must also be disclosed. This policy is intended to openly identify any potential conflict so that participants in an education activity are able to form their own judgments about the presentation. In addition, disclosure must be made of presentations on drugs or devices or uses of drugs or devices that have not been approved by the Food and Drug Administration. 

It is the policy of the American Society of Nutrition, in compliance with the Standards for Integrity and Independence in Accredited Continuing Education to ensure that education presents learners with only accurate, balanced, and scientifically justified recommendations and protects learners from promotion, marketing, and commercial bias. ASN requires disclosure of all financial interest that the planning committee (including ASN staff) or faculty members have with ineligible companies. All faculty and contributors to this continuing education activity have disclosed any relevant financial relationship that may have direct bearing on the subject matter of this program.  Specific disclosure information is in the course materials.

Faculty

Monica Agarwal, MD, MEHP, PNS
University of Alabama at Birmingham
No relevant financial relationship(s) with ineligible companies to disclose.

Jamy Ard, MD
Wake Forest School of Medicine, Department of Epidemiology and Prevention
Boehringer Ingelheim: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Epitomee: Grant/Research Support (Ongoing); KVK Tech: Grant/Research Support (Ongoing); Nestle Health Sciences: Consultant (Ongoing); Grant/Research Support (Ongoing); Novo Nordisk: Advisory Committee/Board Member (Ongoing); Grant/Research Support (Ongoing); Renegeron: Advisory Committee/Board Member (Ongoing); UnitedHealth Group Inc: Consultant (Ongoing); Grant/Research Support (Ongoing); Weight Watchers: Advisory Committee/Board Member (Ongoing); Grant/Research Support (Ongoing)
All of the relevant financial relationships listed for this individual have been mitigated.   

Anupama Chawla, MD
Stony Brook Children's Hospital
Mirum: Consultant (Terminated)
All of the relevant financial relationships listed for this individual have been mitigated.   

Jill Cherry Bukowiec, MD, MS
University of Toledo
No relevant financial relationship(s) with ineligible companies to disclose.

Steven Clinton, MD, PhD
Ohio State University Comprehensive Cancer Center – James; College of Medicine, The Ohio State University Wexner Medical Center
No relevant financial relationship(s) with ineligible companies to disclose.

Nicolaas Deutz, MD, PhD
Texas A&M University
Abbott Nutrition: Speaker/Speaker's Bureau (Ongoing); Danone/Nutricia: Advisory Committee/Board Member (Ongoing)
All of the relevant financial relationships listed for this individual have been mitigated.   

Ihuoma Eneli, MD, MS
University of Colorado School of Medicine Anschutz Medical Campus
No relevant financial relationship(s) with ineligible companies to disclose.

Zhaoping Li, MD, PhD
Center for Human Nutrition, David Geffen School of Medicine at UCLA
No relevant financial relationship(s) with ineligible companies to disclose.

Berkeley Limketkai, MD, PhD
UCLA Center of Inflammatory Bowel Diseases
Azora Therapeutics: Consultant (Ongoing), Stock Shareholder (excluding mutual funds)
All of the relevant financial relationships listed for this individual have been mitigated.   

Octavia Pickett-Blakely, MD, MHS
Penn Medicine
IronWood: Grant/Research Support (Ongoing); Novo Nordisk Pharma Inc.: Consultant (Ongoing); VectivBio: Grant/Research Support (Ongoing)
All of the relevant financial relationships listed for this individual have been mitigated.   

Connie Rhee, MD, MSc
David Geffen School of Medicine at UCLA & VA Greater Los Angeles Healthcare System
AstraZeneca: Advisory Committee/Board Member (Terminated, December 31, 2023), Consultant (Terminated, December 31, 2023); Dexcom: Consultant (Terminated, December 31, 2023), Grant/Research Support (Terminated, December 31, 2023); Fresenius: Advisory Committee/Board Member (Terminated, December 31, 2023), Consultant (Terminated, December 31, 2023); Vifor: Advisory Committee/Board Member (Terminated, December 31, 2023), Consultant (Terminated, December 31, 2023)
All of the relevant financial relationships listed for this individual have been mitigated.   

Staff

Michelle Crispino
American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.

Gwen Twillman
American Society for Nutrition
No relevant financial relationship(s) with ineligible companies to disclose.